Edition:
United Kingdom

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.08USD
12 Oct 2018
Change (% chg)

$0.01 (+0.93%)
Prev Close
$1.07
Open
$1.10
Day's High
$1.10
Day's Low
$1.06
Volume
2,874
Avg. Vol
21,754
52-wk High
$2.64
52-wk Low
$0.84

Chart for

About

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The... (more)

Overall

Beta: 0.46
Market Cap(Mil.): $52.33
Shares Outstanding(Mil.): 37.11
Dividend: --
Yield (%): --

Financials

  GNMX.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -1.02 -- --
ROI: -109.84 1.70 14.60
ROE: -109.84 3.17 16.33

BRIEF-Aevi Genomic Medicine Files For Mixed Shelf Of Up To $50 Mln

* AEVI GENOMIC MEDICINE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source text: (https://bit.ly/2IjWI5B) Further company coverage:

15 May 2018

Earnings vs. Estimates